Dr. Puthen Veettil Jithesh holds a Master’s degree in Microbiology, an Advanced Diploma in Bioinformatics, and received his PhD in Bioinformatics from Queen’s University Belfast, UK. He has over 20 years of research and development experience in Bioinformatics and Computational Biology at several prestigious institutes in India, Qatar, and Russell Group research universities in the UK.
Before moving to Qatar, he was the Head of Bioinformatics for the Oxford Translational Molecular Diagnostic Centre at the University of Oxford and held honorary appointments with the Wellcome Centre for Human Genetics and the Oxford University Hospitals NHS Trust.
College of Health and Life Sciences; Hamad Bin Khalifa University, Doha, Qatar
2020 - PresentCollege of Health and Life Sciences; Hamad Bin Khalifa University, Doha, Qatar
2018 - 2020Translational Bioinformatics; Sidra Medicine, Doha, Qatar
2015 – 2019Translational Molecular Diagnostic Centre; University of Oxford, United Kingdom
2014 – 2015Institute of Translational Medicine; University of Liverpool, United Kingdom
2010 – 2014HealthIntec Limited, Belfast, United Kingdom
2008 – 2012Centre for Cancer Research & Cell Biology; Queen’s University, Belfast, United Kingdom
2006 – 2010Queen’s University, Belfast, United Kingdom
2003 – 2005Centre for Development of Advanced Computing (C-DAC), Pune, India
1999 – 2003Bioinformatics Centre; Indian Institute of Technology (IIT), Kharagpur, India
1999 - 1999School of Medical Education; Mahatma Gandhi University, Kerala, India
1996 - 1998Queen’s University Belfast; Northern Ireland, United Kingdom
2010University of Pune (Now Savitribai Phule Pune University); Maharashtra, India
1999Microbiology; Mahatma Gandhi University; Kerala, India
1994Botany; University of Calicut; Kerala, India
1992Clinical Characteristics and Genomics of Permanent Neonatal Diabetes in The State of Qatar; Molecular Genetics & Genomic Medicine; 2019 (https://doi.org/10.1002/mgg3.753)
2019Integrated Omics Profiling Reveals Novel Patterns of Epigenetic Programming in Cancer-Associated Myofibroblasts; Carcinogenesis 2019, 40(4):500–512 (doi:10.1093/carcin/bgz001)
2019Allen WL, Dunne PD, McDade S, Scanlon E, Loughrey M, Coleman H, McCann C, McLaughlin K, Nemeth Z, Syed N, Jithesh PV, Arthur K, Wilson R, Coyle V, McArt D, Murray G, Samuel L, Nuciforo P, Jimenez J, Argiles G, Dienstmann R, Tabernero J, Messerini L, Nobili S, Mini E, Sheahan K, Ryan E, Johnston PG, Van Schaeybroeck S, Lawler M, Longley DB
2018From Genomes to Genomic Medicine - Enabling Personalised and Precision Medicine in the Middle East; Personalized Medicine; 1 Sep 2017 (doi:10.2217/pme-2017-0048)
2017Accelerating next generation sequencing data analysis with system level optimizations; Scientific Reports 2017, 7:9058 (doi:10.1038/s41598-017-09089-1)
2017Depletion of human DNA in clinical specimens for detection of pathogens by shotgun metagenomic sequencing; Journal of Clinical Microbiology 2016, 54(4):919-27
2016Temple-Baraitser Syndrome and Zimmermann-Laband Syndrome: one clinical entity?;BMC Medical Genetics; 2016, 17(1):42
2016ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer; Cell Reports; 2014, 7(6):1940-55
2014The Epigenetic Landscape of Oral Squamous Cell Carcinoma; British Journal of Cancer; 2013, 108:370-379
2013GeneGrid: architecture, implementation and application; Journal of Grid Computing; 2006, 4:209-222
2006Three copies of four interferon receptor genes underlie mucocutaneous candidiasis and auto-immune thyroiditis in patients with Down Syndrome. Journal of Clinical Immunology (https://doi.org/10.1007/s10875-020-00803-9)
2020Genome sequencing unveils mutational landscape of the familial Mediterranean fever: Potential implications of IL33/ST2 signalling. Journal of Cellular and Molecular Medicine (https://doi.org/10.1111/jcmm.15701)
2020